SDStepan S. Denisov

Stepan S. Denisov

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Stepan S. Denisov has a total of 75 co-authors. Here are the top co-authors by number of shared publications:

  • Ingrid Dijkgraaf

    Department of Biochemistry, Cardiovascular Research Institute Maastricht (CARIM), Maastricht University, Maastricht, the Netherlands

    7 shared publications
  • Galina A. Korshunova

    Belozersky Institute of Physico-Chemical Biology, Lomonosov Moscow State University, Leninskie Gory 1, Moscow 119991, Russia

    5 shared publications
  • Elena A. Kotova

    Belozersky Institute of Physico-Chemical Biology, Lomonosov Moscow State University, Moscow 119991, Russia

    4 shared publications
  • Hans Ippel

    Department of Biochemistry Cardiovascular Research Institute Maastricht (CARIM) Maastricht University Maastricht 6229 ER The Netherlands

    4 shared publications
  • Ljudmila S. Khailova

    Belozersky Institute of Physico-Chemical Biology, Lomonosov Moscow State University, Leninskie Gory 1, Moscow 119991, Russia

    4 shared publications
  • Tilman M. Hackeng

    Department of Biochemistry, Maastricht University, Cardiovascular Research Institute Maastricht (CARIM), Universiteitssingel 50, 6229 ER Maastricht, The Netherlands

    4 shared publications

Latest Publications

  • Open Access

    Chemokine-Binding All-D-CLIPS Peptides Identified Using Mirror-Image Phage Display

    by Stepan S. Denisov, Emilia L. Bialek, Fabio Beretta, Gintare Smagurauskaite, Hans Ippel, Eline Fijlstra, Sangram S. Kale, Peter Timmerman, Tilman M. Hackeng, Paul Proost, et al.

    Chemokines are secreted blood proteins that steer leukocyte migration in the inflammatory response. Neutralization of chemokines is believed to be a beneficial therapeutic strategy for the treatment of inflammation-associated diseases. Proteolytically stable chemokine-binding peptides could be suitable candidates for the development of chemokine-neutralizing agents. Here, we report the mirror-image phage display selection of cyclic all-D-peptides against the C-X-C motif chemokine ligand 8 (CXCL8). Selection yielded structurally diverse all-D-peptides with submicromolar affinity to the target CXCL8 chemokine and different selectivity to related chemokines. Binding of these all-D-peptides caused dissociation of the native CXCL8 dimer and disruption of its binding to GAGs, without an effect on in vitro cell migration. This work demonstrates the example of mirror-image phage display selection of cyclized all-D-peptides and its utility for the development of chemokine-binding agents.


  • Open Access

    Chemokine-binding all-D-CLIPS™ peptides identified using mirror-image phage display

    by Stepan S. Denisov, Emilia L. Bialek, Fabio Beretta, Gintare Smagurauskaite, Johannes H. Ippel, Eline Fijlstra, Sangram S. Kale, Peter Timmerman, Tilman M. Hackeng, Paul Proost, et al.

    Chemokines are secreted blood proteins, which steer leukocyte migration in the inflammatory response. Neutralization of chemokines is believed to be a beneficial therapeutic strategy for the treatment of inflammation-associated diseases. Proteolytically stable chemokine-binding peptides could be suitable candidates for the development of chemokine-neutralizing agents. Here, we report mirror-image phage display selection of cyclic all-D-peptides against the C-X-C motif chemokine ligand 8 (CXCL8). Selection yielded structurally diverse all-D-peptides with sub-micromolar affinity to the target CXCL8 chemokine and different selectivity to related chemokines. Binding of these all-D-peptides caused dissociation of the native CXCL8 dimer and disruption of its binding to GAGs, without effect on in vitro cell migration. This work demonstrates the example of mirror-image phage display selection of cyclized all-D-peptides and its utility for the development of chemokine-binding agents.

  • Open Access

    Unravelling the Functional Diversity of Type III Polyketide Synthases in Fungi

    by Nika Sokolova, Stepan S. Denisov, Thomas Hackl, Kristina Haslinger

    Type III polyketide synthases (T3PKSs) are enzymes that produce diverse compounds of ecological and clinical importance. While well‐studied in plants, only a handful of T3PKSs from fungi have been characterised to date. Here, we developed a comprehensive workflow for kingdom‐wide characterisation of T3PKSs. Using publicly available genomes, we mined more than 1000 putative enzymes and analysed their active site architecture and genomic neighbourhood. From there, we selected 37 representative PKS candidates for cell‐free expression and prototyping with a diverse set of Coenzyme A activated substrates, revealing unique patterns in substrate and cyclisation specificity, as well as the preferred number of malonyl‐Coenzyme A extensions. Using the 341 enzyme‐substrate pairs generated in this study, we trained a machine learning model to predict T3PKS substrate specificity and experimentally validated it with an extended panel of non‐natural substrates. In addition, we applied the model to identify two more promiscuous T3PKSs from fungi. We anticipate that the ML model will be useful for in silico screening of T3PKSs, while the insight into the product scope of these enzymes offers interesting starting points for further exploration.

  • Open Access

    Unravelling the Functional Diversity of Type III Polyketide Synthases in Fungi

    by Nika Sokolova, Stepan S. Denisov, Thomas Hackl, Kristina Haslinger

    Type III polyketide synthases (T3PKSs) are enzymes that produce diverse compounds of ecological and clinical importance. While well‐studied in plants, only a handful of T3PKSs from fungi have been characterised to date. Here, we developed a comprehensive workflow for kingdom‐wide characterisation of T3PKSs. Using publicly available genomes, we mined more than 1000 putative enzymes and analysed their active site architecture and genomic neighbourhood. From there, we selected 37 representative PKS candidates for cell‐free expression and prototyping with a diverse set of Coenzyme A activated substrates, revealing unique patterns in substrate and cyclisation specificity, as well as the preferred number of malonyl‐Coenzyme A extensions. Using the 341 enzyme‐substrate pairs generated in this study, we trained a machine learning model to predict T3PKS substrate specificity and experimentally validated it with an extended panel of non‐natural substrates. In addition, we applied the model to identify two more promiscuous T3PKSs from fungi. We anticipate that the ML model will be useful for in silico screening of T3PKSs, while the insight into the product scope of these enzymes offers interesting starting points for further exploration.


  • Open Access

    Evasin and TSLPI Tick Salivary Antigen Subunit Vaccine Nanoparticles Induce Humoral and Cellular Immunity

    by Jaeyoung Park, Thomas Pho, Stepan S. Denisov, Ingrid Dijkgraaf, Julie A. Champion

    Tick-borne diseases have increased significantly due to several factors, including climate change. Ticks can carry diverse pathogens, and transmission is facilitated by immunosuppressive tick salivary proteins. Vaccination targeting tick salivary proteins has been proposed as a strategy to enhance broad acquired immunity against tick-borne pathogens. Given the immunosuppressive nature of these proteins, we leveraged the ability of nanoparticles to enhance antigen immunogenicity. We synthesized nanoparticles directly from tick salivary proteins, evasin-3 and tick salivary lectin pathway inhibitor (TSLPI), by desolvation with ethanol and cross-linking. Nanoparticles formulated with the CpG oligonucleotide adjuvant significantly enhanced both humoral and cellular immune responses against both evasin-3 and TSLPI in mice compared to soluble CpG adjuvanted antigens. These results demonstrate the importance of antigen delivery and presentation, particularly for poorly immunogenic antigens, and the potential for protein nanoparticles to be developed as vaccines against diverse tick-borne pathogens.


  • Open Access

    Discovery and pharmacophoric characterization of chemokine network inhibitors using phage-display, saturation mutagenesis and computational modelling

    by Serena Vales, Jhanna Kryukova, Soumyanetra Chandra, Gintare Smagurauskaite, Megan Payne, Charlie J. Clark, Katrin Hafner, Philomena Mburu, Stepan Denisov, Graham Davies, et al.

    CC and CXC-chemokines are the primary drivers of chemotaxis in inflammation, but chemokine network redundancy thwarts pharmacological intervention. Tick evasins promiscuously bind CC and CXC-chemokines, overcoming redundancy. Here we show that short peptides that promiscuously bind both chemokine classes can be identified from evasins by phage-display screening performed with multiple chemokines in parallel. We identify two conserved motifs within these peptides and show using saturation-mutagenesis phage-display and chemotaxis studies of an exemplar peptide that an anionic patch in the first motif and hydrophobic, aromatic and cysteine residues in the second are functionally necessary. AlphaFold2-Multimer modelling suggests that the peptide occludes distinct receptor-binding regions in CC and in CXC-chemokines, with the first and second motifs contributing ionic and hydrophobic interactions respectively. Our results indicate that peptides with broad-spectrum anti-chemokine activity and therapeutic potential may be identified from evasins, and the pharmacophore characterised by phage display, saturation mutagenesis and computational modelling.


  • Open Access

    Molecular basis of anticoagulant and anticomplement activity of the tick salivary protein Salp14 and its homologs

    by Stepan S. Denisov, Johannes H. Ippel, Elisabetta Castoldi, Ben J. Mans, Tilman M. Hackeng, Ingrid Dijkgraaf


  • Open Access

    Structural characterization of anti-CCL5 activity of the tick salivary protein evasin-4

    by Stepan S. Denisov, Mercedes Ramírez-Escudero, Alexandra C. A. Heinzmann, Johannes H. Ippel, Philip E. Dawson, Rory R. Koenen, Tilman M. Hackeng, Bert J. C. Janssen, Ingrid Dijkgraaf


  • Open Access

    Tick Saliva Protein Evasin-3 Allows for Visualization of Inflammation in Arteries through Interactions with CXC-Type Chemokines Deposited on Activated Endothelium

    by Stepan S. Denisov, Alexandra C. A. Heinzmann, Tanja Vajen, Mark H. M. Vries, Remco T. A. Megens, Dennis Suylen, Rory R. Koenen, Mark J. Post, Johannes H. Ippel, Tilman M. Hackeng, et al.

    Atherosclerosis is one of the leading causes of mortality in developed and developing countries. The onset of atherosclerosis development is accompanied by overexpression of several inflammatory chemokines. Neutralization of these chemokines by chemokine-binding agents attenuates atherosclerosis progression. Here, we studied structural binding features of the tick protein Evasin-3 to chemokine (C-X-C motif) ligand 1 (CXCL1). We showed that Evasin-3-bound CXCL1 is unable to activate the CXCR2 receptor, but retains affinity to glycosaminoglycans. This observation was exploited to detect inflammation by visualizing a group of closely related CXC-type chemokines deposited on cell walls in human endothelial cells and murine carotid arteries by a fluorescent Evasin-3 conjugate. This work highlights the applicability of tick-derived chemokine-binding conjugates as a platform for the development of new agents for inflammation imaging.


  • Open Access

    Tick saliva protein Evasin-3 modulates chemotaxis by disrupting CXCL8 interactions with glycosaminoglycans and CXCR2

    by Stepan S. Denisov, Johannes H. Ippel, Alexandra C. A. Heinzmann, Rory R. Koenen, Almudena Ortega-Gomez, Oliver Soehnlein, Tilman M. Hackeng, Ingrid Dijkgraaf